BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 16167344)

  • 1. Angiostatic activity of human plasminogen fragments is highly dependent on glycosylation.
    Santos IC; Silbiger VN; Higuchi DA; Gomes MA; Barcelos LS; Teixeira MM; Lopes MT; Cardoso VN; Lima MP; Araujo RC; Pesquero JB; Pesquero JL
    Cancer Sci; 2010 Feb; 101(2):453-9. PubMed ID: 19961492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen kringle 5 suppresses gastric cancer via regulating HIF-1α and GRP78.
    Fang S; Hong H; Li L; He D; Xu Z; Zuo S; Han J; Wu Q; Dai Z; Cai W; Ma J; Shao C; Gao G; Yang X
    Cell Death Dis; 2017 Oct; 8(10):e3144. PubMed ID: 29072683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen kringle 5 induces endothelial cell apoptosis by triggering a voltage-dependent anion channel 1 (VDAC1) positive feedback loop.
    Li L; Yao YC; Gu XQ; Che D; Ma CQ; Dai ZY; Li C; Zhou T; Cai WB; Yang ZH; Yang X; Gao GQ
    J Biol Chem; 2014 Nov; 289(47):32628-38. PubMed ID: 25296756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual inhibition of plasminogen kringle 5 on angiogenesis and chemotaxis suppresses tumor metastasis by targeting HIF-1α pathway.
    Cai WB; Zhang Y; Cheng R; Wang Z; Fang SH; Xu ZM; Yang X; Yang ZH; Ma JX; Shao CK; Gao GQ
    PLoS One; 2012; 7(12):e53152. PubMed ID: 23300882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High efficacy and minimal peptide required for the anti-angiogenic and anti-hepatocarcinoma activities of plasminogen K5.
    Yang X; Cai W; Xu Z; Chen J; Li C; Liu S; Yang Z; Pan Q; Li M; Ma J; Gao G
    J Cell Mol Med; 2010 Oct; 14(10):2519-30. PubMed ID: 20050964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and development of anti-angiogenic peptides: A structural link.
    Dings RP; Nesmelova I; Griffioen AW; Mayo KH
    Angiogenesis; 2003; 6(2):83-91. PubMed ID: 14739615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A deletion mutant of plasminogen kringle 5 inhibits retinal capillary endothelial cell proliferation].
    Ma JF; Yang ZH; Li CY; Cai WB; Song ZH; Guo Y; Guo LL; Li MY; Liu ZG; Gao GQ
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Dec; 23(12):1245-8. PubMed ID: 14678880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation of human plasminogen kringle 1-5 enhances anti-angiogenic action via increased interaction with integrin alpha(v)beta(3).
    Chang PC; Chang YJ; Wu HL; Chang CW; Lin CI; Wang WC; Shi GY
    Thromb Haemost; 2008 Apr; 99(4):729-38. PubMed ID: 18392331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preparation and functional study of an adenovirus vector expressing human plasminogen kringle 5 gene].
    Yang J; Wang YX; Guan XQ; Ma CG; Wang LS; Song HY
    Sheng Wu Gong Cheng Xue Bao; 2003 Mar; 19(2):217-22. PubMed ID: 15966325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen kringle 5-engineered glioma cells block migration of tumor-associated macrophages and suppress tumor vascularization and progression.
    Perri SR; Nalbantoglu J; Annabi B; Koty Z; Lejeune L; François M; Di Falco MR; Béliveau R; Galipeau J
    Cancer Res; 2005 Sep; 65(18):8359-65. PubMed ID: 16166313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal injection of plasminogen kringle 5, an endogenous angiogenic inhibitor, arrests retinal neovascularization in rats.
    Zhang D; Kaufman PL; Gao G; Saunders RA; Ma JX
    Diabetologia; 2001 Jun; 44(6):757-65. PubMed ID: 11440369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced anti-angiogenic effect of a deletion mutant of plasminogen kringle 5 on neovascularization.
    Cai W; Ma J; Li C; Yang Z; Yang X; Liu W; Liu Z; Li M; Gao G
    J Cell Biochem; 2005 Dec; 96(6):1254-61. PubMed ID: 16167344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis--a new target for future therapy.
    Pandya NM; Dhalla NS; Santani DD
    Vascul Pharmacol; 2006 May; 44(5):265-74. PubMed ID: 16545987
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.